Oral Nutritional Supplement in Reducing Surgical Site Infections

NCT02475525 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2018-05-04

No results posted yet for this study

Summary

The study aims to evaluate the efficacy of an arginine enriched oral nutritional supplement in the prevention of wound complications in the the wounds of patients post lower limb revascularization.

Conditions

  • Peripheral Vascular Disease
  • Claudication

Interventions

DIETARY_SUPPLEMENT

Arginine enriched oral nutritional supplement

oral nutritional supplement containing arginine

Sponsors & Collaborators

  • UL Hospitals, Limerick

    collaborator UNKNOWN
  • University of Limerick

    lead OTHER

Principal Investigators

  • Mary Clarke Moloney · University of Limerick

  • Paul Burke · UL Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-12-01
Completion
2017-02-01

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02475525 on ClinicalTrials.gov